Development, characterization and stability of therapeutic protein co-formulations
D Krieg - 2021 - edoc.ub.uni-muenchen.de
Protein therapeutics have steadily gained importance for the targeted pharmacotherapy of
severe diseases in the last decades. The specific targeting of a single antigen has proven to …
severe diseases in the last decades. The specific targeting of a single antigen has proven to …
Development, characterization and stability of therapeutic protein co-formulations
D Krieg - 2021 - edoc.ub.uni-muenchen.de
Protein therapeutics have steadily gained importance for the targeted pharmacotherapy of
severe diseases in the last decades. The specific targeting of a single antigen has proven to …
severe diseases in the last decades. The specific targeting of a single antigen has proven to …
[PDF][PDF] Development, characterization and stability of therapeutic protein co-formulations
D Krieg - scholar.archive.org
Protein therapeutics have steadily gained importance for the targeted pharmacotherapy of
severe diseases in the last decades. Until 2019, 79 therapeutic monoclonal antibodies …
severe diseases in the last decades. Until 2019, 79 therapeutic monoclonal antibodies …
[PDF][PDF] Development, characterization and stability of therapeutic protein co-formulations
D Krieg - d-nb.info
Protein therapeutics have steadily gained importance for the targeted pharmacotherapy of
severe diseases in the last decades. Until 2019, 79 therapeutic monoclonal antibodies …
severe diseases in the last decades. Until 2019, 79 therapeutic monoclonal antibodies …